Braveheart Bio, Inc. (BRVE) vs Nutex Health, Inc. (NUTX)

A side-by-side comparison of Braveheart Bio, Inc. and Nutex Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BRVE

Braveheart Bio, Inc.

$1.45B

$20.46HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

NUTX

Nutex Health, Inc.

$1.54B

$223.58HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — BRVE vs NUTX

growth of $100 · dividends reinvested · last 1y

BRVE +18.6% (+18.6%/yr)NUTX +47.1% (+47.1%/yr)NUTX compounded faster over this window

BRVE NUTX

Metrics side by side

Total return (annualized)

Metric	BRVE	NUTX
Total return (1Y)	N/A	107.84%
Total return CAGR (3Y)	N/A	97.37%
Total return CAGR (5Y)	N/A	-18.99%
Total return CAGR (10Y)	N/A	-27.99%

BRVE is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full BRVE analysis Full NUTX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.